1,708 results on '"Döhner, Konstanze"'
Search Results
2. FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN)
3. ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
4. Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype
5. Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients
6. Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts
7. Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients
8. Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen
9. Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease
10. Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study
11. Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin
12. In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts
13. Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)
14. AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technology
15. Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
16. Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group
17. First-in-human study of WT1 recombinant protein vaccination in elderly patients with AML in remission: a single-center experience
18. Correction: Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients
19. Netboost: Boosting-supported network analysis improves high-dimensional omics prediction in acute myeloid leukemia and Huntington's disease
20. Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09–09): a randomised, open-label, multicentre, phase 3 trial
21. Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
22. UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment
23. Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications
24. Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia
25. Unified classification and risk-stratification in Acute Myeloid Leukemia
26. PLCG1 is required for AML1-ETO leukemia stem cell self-renewal
27. Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results
28. Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial
29. Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations
30. Deregulated expression of circular RNAs in acute myeloid leukemia
31. Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis
32. Germline variants drive myelodysplastic syndrome in young adults
33. Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome—excess blasts detected by next-generation sequencing technique
34. Activating JAK-mutations confer resistance to FLT3 kinase inhibitors in FLT3-ITD positive AML in vitro and in vivo
35. Genomic characterization of AML with aberrations of chromosome 7:a multinational cohort of 519 patients
36. Precision hematology:Navigating the evolution of diagnostic classifications in the era of globalized medicine
37. Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial
38. Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication
39. Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial
40. Wer ist ... Konstanze Döhner?
41. TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition
42. Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia
43. Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study
44. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells
45. Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis
46. Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)
47. Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)
48. Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
49. The ParaHox gene Cdx4 induces acute erythroid leukemia in mice
50. Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.